These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 9105549

  • 1. Cefodizime given in single or divided doses for the treatment of lower respiratory tract infection.
    Palombini BC, André-Alves MR, Dagrosa EE.
    Arzneimittelforschung; 1997 Mar; 47(3):299-302. PubMed ID: 9105549
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cefodizime and cefotaxime in acute exacerbations of chronic bronchitis: a randomized double-blind prospective study in 180 patients.
    Maesen FP, Davies BI, van den Bergh JJ, Gubbelmans HL, Meek JC, Geraedts WH.
    J Antimicrob Chemother; 1990 Mar; 25(3):413-22. PubMed ID: 2187013
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An open multicentre study of the efficacy and tolerance of cefodizime 1 g bd intravenously or intramuscularly in lower respiratory tract infections.
    Sollet JP.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():103-10. PubMed ID: 2074244
    [Abstract] [Full Text] [Related]

  • 8. [Bacteriological and clinical studies of cefodizime in pediatrics].
    Akita H, Sato Y, Iwata S, Sunakawa K.
    Jpn J Antibiot; 1991 Apr; 44(4):398-411. PubMed ID: 1880919
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical evaluation and immunomodulatory study of cefodizime].
    Li G, Zhang Y, Ji M.
    Zhonghua Nei Ke Za Zhi; 1997 Nov; 36(11):759-63. PubMed ID: 10451950
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of ceftizoxime administered twice daily in hospitalized patients with respiratory tract infections.
    Lentnek A, Wikler M, McDevitt J, Sohn C.
    Clin Ther; 1984 Nov; 7(1):33-9. PubMed ID: 6097357
    [Abstract] [Full Text] [Related]

  • 13. Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections.
    Beumer HM.
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):30-3. PubMed ID: 2663735
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of once-daily cephalosporin regimens for community-acquired lower respiratory tract infections in patients with chronic lung disease.
    McCabe RE, Schlossberg D, Donowitz GR, Scheld WM, Zellner SR, Lindenberg LB, Armstrong JH, Ein ME.
    Clin Ther; 1989 Jan; 11(3):304-14. PubMed ID: 2663160
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cefodizime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Barradell LB, Brogden RN.
    Drugs; 1992 Nov; 44(5):800-34. PubMed ID: 1280568
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.